Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Favourable regulatory scenario in developed nations
3.2.1.2 Growing inclination towards planned delayed pregnancy
3.2.1.3 High unmet contraceptive needs in developing economies
3.2.1.4 Growing prevalence of sexually transmitted diseases (STD)
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects of contraceptive drugs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Pricing trends
3.7 Consumer behavior analysis
3.8 Technology landscape
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Devices
5.2.1 Condoms
5.2.1.1 Male
5.2.1.2 Female
5.2.2 Intra-uterine devices
5.2.2.1 Hormonal IUD
5.2.2.2 Copper IUD
5.2.3 Vaginal rings
5.2.4 Subdermal implants
5.2.5 Diaphragms
5.2.6 Contraceptive sponges
5.3 Drugs
5.3.1 Oral contraceptive pills
5.3.2 Injectable contraceptives
5.3.3 Topical contraceptives
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 15 - 44 years
6.3 Above 44 years
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Retail pharmacies
7.3 Hospital pharmacies
7.4 Online channels
7.5 Other distribution channels
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Afaxys, Inc.
9.2 Agile Therapeutics
9.3 Amneal Pharmaceuticals
9.4 Bayer AG
9.5 Church & Dwight Co., Inc.
9.6 Cooper Companies
9.7 Evofem Biosciences
9.8 HRA Pharma
9.9 Maxwellia Ltd
9.10 Mayer Laboratories, Inc.
9.11 Mithra Pharmaceuticals
9.12 Organon & Co.
9.13 Pfizer, Inc.
9.14 Reckitt Benckiser Group PLC
9.15 TherapeuticsMD, Inc.
9.16 Veru, Inc.
